ANO2 and myeloid sarcoma: Although the search for autoantigen in patients with multiple sclerosis has been ongoing for decades and several proteins have been postulated to be potent autoantigens, such as α B-crystallin [37], anoctamin 2 [38], and KIR4.1 [39], the exact target autoantigen of MS remains unclear.